CBA
NKTR icon

Coastal Bridge Advisors’s Nektar Therapeutics NKTR Stock Holding History

Coastal Bridge Advisors’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-667
Closed -$6.8K – 455
2025
Q1 		$6.8K Buy
+667
New +$8.71K ﹤0.01% 422

Other funds holding NKTR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Coastal Bridge Advisors's NKTR Position: Q2 2025 in Review

Coastal Bridge Advisors sold out of Nektar Therapeutics (NKTR) in Q2 2025, closing a stake of 667 shares — an estimated $6.8K sold.

Coastal Bridge Advisors first reported a position in NKTR in Q1 2025 and held it in 1 quarter. The position peaked at $6.8K in Q1 2025. 109 funds tracked by Wall St. Rank hold NKTR as of Q2 2025.

  • Coastal Bridge Advisors reported no remaining Nektar Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Coastal Bridge Advisors sold 667 Nektar Therapeutics shares in Q2 2025, an estimated $6.8K.
  • Coastal Bridge Advisors first reported a position in Nektar Therapeutics in Q1 2025 and held it in 1 quarter.
  • Coastal Bridge Advisors's Nektar Therapeutics position peaked at $6.8K in Q1 2025.
  • 109 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2025.

Based on Coastal Bridge Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.